well streptavidin coated plates (Greiner Bio)
94
Structured Review
Greiner Bio
well streptavidin coated plates
Well Streptavidin Coated Plates, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 94/100, based on 25 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/well+streptavidin+coated+plates/Microplate+96+Well+Ps+C-Bottom+White/pm41932811-58-55-61
Average 94 stars, based on 25 article reviews
Well Streptavidin Coated Plates, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 94/100, based on 25 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/well+streptavidin+coated+plates/Microplate+96+Well+Ps+C-Bottom+White/pm41932811-58-55-61
Average 94 stars, based on 25 article reviews
well streptavidin coated plates - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy. Article Snippet: .. Plasma levels of PRO- PAR- 2 in clinical samples were measured by quantitative competitive chemiluminescence assay at the Nordic Bioscience Laboratory (Denmark) as previously described.1 Briefly, 2 ng/mL biotinylated peptide dissolved in assay buffer (25 mM PBS- BTB, 1% BSA, 0.1% Tween- 20, 0.36% Bronidox, and 8 g/L NaCl, pH 7.4) was added to 96- Chemiluminescence Immunoassay:Article Title: Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy. Article Snippet: .. Plasma levels of PRO- PAR- 2 in clinical samples were measured by quantitative competitive chemiluminescence assay at the Nordic Bioscience Laboratory (Denmark) as previously described.1 Briefly, 2 ng/mL biotinylated peptide dissolved in assay buffer (25 mM PBS- BTB, 1% BSA, 0.1% Tween- 20, 0.36% Bronidox, and 8 g/L NaCl, pH 7.4) was added to 96- Incubation:Article Title: Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy. Article Snippet: .. Plasma levels of PRO- PAR- 2 in clinical samples were measured by quantitative competitive chemiluminescence assay at the Nordic Bioscience Laboratory (Denmark) as previously described.1 Briefly, 2 ng/mL biotinylated peptide dissolved in assay buffer (25 mM PBS- BTB, 1% BSA, 0.1% Tween- 20, 0.36% Bronidox, and 8 g/L NaCl, pH 7.4) was added to 96- |